Biotechnology
The Biotechnology industry has a total of 584 stocks, with a combined market cap of $1.23 trillion and total revenue of $109.16 billion.
Market Cap
1.23T
Revenue
109.16B
Profits
-41.15B
PE Ratio
n/a
Profit Margin
-37.70%
Dividend Yield
0.04%
584 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 121.12B | -0.99% | 182,375 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 68.43B | -0.38% | 82,828 | 14.92B |
| 3 | ARGX | argenx SE | 54.26B | -0.91% | 54,784 | 4.74B |
| 4 | RVMD | Revolution Medicines, Inc. | 39.01B | 0.11% | 184,883 | - |
| 5 | ONC | BeOne Medicines AG | 35.96B | 1.49% | 184,229 | 5.74B |
| 6 | ALNY | Alnylam Pharmaceuticals, Inc. | 35.78B | -1.26% | 179,096 | 4.29B |
| 7 | RPRX | Royalty Pharma plc | 33.69B | 0.14% | 405,862 | 2.44B |
| 8 | ROIV | Roivant Sciences Ltd. | 24.97B | -0.70% | 685,596 | 8.26M |
| 9 | INCY | Incyte Corporation | 23.45B | - | 192,679 | 5.36B |
| 10 | INSM | Insmed Incorporated | 23.38B | -0.70% | 231,888 | 819.56M |
| 11 | BNTX | BioNTech SE | 23.36B | 0.04% | 125,544 | 3.23B |
| 12 | MRNA | Moderna, Inc. | 23.35B | -1.36% | 1,031,298 | 2.23B |
| 13 | GMAB | Genmab A/S | 17.36B | 2.98% | 633,266 | 3.90B |
| 14 | ASND | Ascendis Pharma A/S | 16.69B | -0.77% | 65,417 | 998.25M |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 16.01B | 0.24% | 70,449 | 4.44B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 15.97B | -1.21% | 239,569 | 579.96M |
| 17 | EXEL | Exelixis, Inc. | 14.00B | -0.75% | 286,768 | 2.38B |
| 18 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.83B | 22.25% | 3,052,042 | 622.01M |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.68B | 0.54% | 130,027 | 1.13B |
| 20 | AXSM | Axsome Therapeutics, Inc. | 12.22B | 0.18% | 108,790 | 708.24M |
| 21 | SMMT | Summit Therapeutics Inc. | 11.68B | 2.87% | 1,278,656 | - |
| 22 | ABVX | ABIVAX Société Anonyme | 11.56B | -1.80% | 217,115 | 5.67M |
| 23 | BMRN | BioMarin Pharmaceutical Inc. | 11.51B | 0.61% | 438,401 | 3.24B |
| 24 | CYTK | Cytokinetics, Incorporated | 11.17B | 1.39% | 210,566 | 105.82M |
| 25 | TECH | Bio-Techne Corporation | 11.15B | -0.08% | 669,615 | 1.21B |
| 26 | APGE | Apogee Therapeutics, Inc. | 10.08B | 0.06% | 212,620 | - |
| 27 | KRYS | Krystal Biotech, Inc. | 10.02B | 0.22% | 59,384 | 417.30M |
| 28 | CORT | Corcept Therapeutics Incorporated | 10.01B | -2.50% | 81,003 | 769.10M |
| 29 | HALO | Halozyme Therapeutics, Inc. | 9.36B | 0.43% | 286,097 | 1.51B |
| 30 | KYMR | Kymera Therapeutics, Inc. | 9.19B | -1.45% | 50,949 | 51.48M |
| 31 | SYRE | Spyre Therapeutics, Inc. | 8.87B | -1.74% | 87,933 | - |
| 32 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.84B | -0.02% | 741,845 | 18.07M |
| 33 | PTGX | Protagonist Therapeutics, Inc. | 8.77B | -1.45% | 172,513 | 74.06M |
| 34 | PRAX | Praxis Precision Medicines, Inc. | 8.64B | -2.53% | 46,628 | 7.46M |
| 35 | IONS | Ionis Pharmaceuticals, Inc. | 8.59B | -2.60% | 3,164,702 | 1.06B |
| 36 | PCVX | Vaxcyte, Inc. | 8.23B | -1.83% | 383,701 | - |
| 37 | IBRX | ImmunityBio, Inc. | 8.10B | -4.15% | 2,080,288 | 140.98M |
| 38 | IMVT | Immunovant, Inc. | 8.00B | -1.37% | 90,503 | - |
| 39 | TGTX | TG Therapeutics, Inc. | 7.55B | -1.30% | 210,758 | 700.35M |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.16B | -2.04% | 104,256 | 217.17M |
| 41 | MIRM | Mirum Pharmaceuticals, Inc. | 7.04B | -1.31% | 45,524 | 569.61M |
| 42 | COGT | Cogent Biosciences, Inc. | 6.66B | -1.64% | 139,881 | - |
| 43 | ERAS | Erasca, Inc. | 6.57B | -2.32% | 361,371 | - |
| 44 | PTCT | PTC Therapeutics, Inc. | 6.50B | -0.10% | 91,471 | 827.11M |
| 45 | XENE | Xenon Pharmaceuticals Inc. | 6.39B | -0.96% | 84,556 | 7.50M |
| 46 | CGON | CG Oncology, Inc. | 6.25B | -1.17% | 79,553 | 5.07M |
| 47 | BLTE | Belite Bio, Inc | 6.20B | -2.14% | 49,250 | - |
| 48 | LGND | Ligand Pharmaceuticals Incorporated | 6.03B | -0.37% | 51,152 | 274.48M |
| 49 | SRRK | Scholar Rock Holding Corporation | 5.96B | -2.18% | 89,339 | - |
| 50 | DFTX | Definium Therapeutics, Inc. | 5.82B | -2.68% | 196,261 | - |
| 51 | DNTH | Dianthus Therapeutics, Inc. | 5.70B | -1.43% | 245,291 | 1.34M |
| 52 | ORKA | Oruka Therapeutics, Inc. | 5.69B | -0.03% | 192,651 | - |
| 53 | TVTX | Travere Therapeutics, Inc. | 5.19B | -1.27% | 132,717 | 536.20M |
| 54 | CRSP | CRISPR Therapeutics AG | 4.68B | -1.20% | 322,805 | 4.10M |
| 55 | MANE | Veradermics, Incorporated | 4.62B | 0.97% | 54,679 | - |
| 56 | LEGN | Legend Biotech Corporation | 4.55B | -0.17% | 120,710 | 1.14B |
| 57 | CELC | Celcuity Inc. | 4.47B | -0.13% | 264,219 | - |
| 58 | CAI | Caris Life Sciences, Inc. | 4.33B | -2.54% | 305,071 | 907.29M |
| 59 | VKTX | Viking Therapeutics, Inc. | 4.33B | -1.71% | 202,585 | - |
| 60 | ACAD | ACADIA Pharmaceuticals Inc. | 4.29B | -1.49% | 187,675 | 1.10B |
| 61 | EWTX | Edgewise Therapeutics, Inc. | 4.21B | -1.24% | 124,930 | - |
| 62 | RLAY | Relay Therapeutics, Inc. | 4.16B | -1.04% | 253,959 | 10.68M |
| 63 | TNGX | Tango Therapeutics, Inc. | 4.11B | -2.00% | 162,064 | 56.99M |
| 64 | PBLS | Parabilis Medicines, Inc. | 3.79B | -0.83% | 38,335 | - |
| 65 | DNLI | Denali Therapeutics Inc. | 3.76B | -0.67% | 244,988 | - |
| 66 | ELVN | Enliven Therapeutics, Inc. | 3.73B | -1.60% | 68,599 | - |
| 67 | ALMS | Alumis Inc. | 3.73B | -2.66% | 198,286 | 8.40M |
| 68 | DYN | Dyne Therapeutics, Inc. | 3.70B | -6.17% | 3,247,909 | - |
| 69 | RCUS | Arcus Biosciences, Inc. | 3.68B | -0.64% | 99,589 | 236.00M |
| 70 | NAMS | NewAmsterdam Pharma Company N.V. | 3.68B | -2.78% | 87,539 | 22.57M |
| 71 | TLX | Telix Pharmaceuticals Limited | 3.54B | -4.53% | 101,788 | 803.79M |
| 72 | GPCR | Structure Therapeutics Inc. | 3.50B | -0.10% | 155,452 | - |
| 73 | ARQT | Arcutis Biotherapeutics, Inc. | 3.48B | -1.49% | 90,452 | 415.62M |
| 74 | IDYA | IDEAYA Biosciences, Inc. | 3.36B | -1.83% | 51,276 | 225.27M |
| 75 | IRON | Disc Medicine, Inc. | 2.82B | -2.21% | 63,031 | - |
| 76 | MBX | MBX Biosciences, Inc. | 2.76B | -3.75% | 103,325 | - |
| 77 | RARE | Ultragenyx Pharmaceutical Inc. | 2.74B | -2.41% | 154,823 | 670.00M |
| 78 | QURE | uniQure N.V. | 2.71B | -1.57% | 131,245 | 18.09M |
| 79 | BEAM | Beam Therapeutics Inc. | 2.66B | -2.09% | 213,648 | 164.01M |
| 80 | CLDX | Celldex Therapeutics, Inc. | 2.66B | -5.05% | 701,991 | 865.00K |
| 81 | ATAI | AtaiBeckley Inc. | 2.64B | 0.14% | 2,123,959 | 3.49M |
| 82 | KOD | Kodiak Sciences Inc. | 2.64B | -0.40% | 85,239 | - |
| 83 | VERA | Vera Therapeutics, Inc. | 2.62B | -1.91% | 156,341 | - |
| 84 | IMNM | Immunome, Inc. | 2.58B | 0.18% | 77,453 | 4.02M |
| 85 | TARS | Tarsus Pharmaceuticals, Inc. | 2.52B | 2.38% | 170,500 | 535.08M |
| 86 | TRVI | Trevi Therapeutics, Inc. | 2.45B | -5.12% | 205,342 | - |
| 87 | NRIX | Nurix Therapeutics, Inc. | 2.41B | -1.06% | 149,076 | 36.77M |
| 88 | PHVS | Pharvaris N.V. | 2.41B | 0.10% | 67,557 | - |
| 89 | KLRA | Kailera Therapeutics, Inc. | 2.40B | 0.60% | 194,959 | - |
| 90 | SLS | SELLAS Life Sciences Group, Inc. | 2.39B | -5.58% | 2,310,244 | - |
| 91 | MLYS | Mineralys Therapeutics, Inc. | 2.37B | -2.14% | 84,315 | - |
| 92 | ZLAB | Zai Lab Limited | 2.33B | 1.37% | 61,931 | 453.28M |
| 93 | NKTR | Nektar Therapeutics | 2.33B | 0.33% | 165,431 | 55.63M |
| 94 | IOVA | Iovance Biotherapeutics, Inc. | 2.32B | -5.29% | 5,268,386 | 285.61M |
| 95 | VCEL | Vericel Corporation | 2.30B | -2.47% | 88,287 | 292.09M |
| 96 | COAG | Hemab Therapeutics Holdings, Inc. | 2.29B | 1.45% | 27,647 | - |
| 97 | BHVN | Biohaven Ltd. | 2.23B | -4.45% | 319,356 | - |
| 98 | AGIO | Agios Pharmaceuticals, Inc. | 2.18B | -1.82% | 184,852 | 66.05M |
| 99 | NUVB | Nuvation Bio Inc. | 2.18B | -2.72% | 1,281,160 | 143.05M |
| 100 | MESO | Mesoblast Limited | 2.13B | -0.18% | 20,682 | 65.38M |
| 101 | HRMY | Harmony Biosciences Holdings, Inc. | 2.11B | -1.14% | 124,536 | 899.11M |
| 102 | URGN | UroGen Pharma Ltd. | 2.11B | -1.30% | 116,722 | 140.49M |
| 103 | VRDN | Viridian Therapeutics, Inc. | 2.09B | -1.15% | 238,798 | 70.92M |
| 104 | KARD | Kardigan, Inc. | 2.06B | 0.52% | 57,587 | - |
| 105 | SION | Sionna Therapeutics, Inc. | 2.03B | -4.70% | 84,293 | - |
| 106 | PVLA | Palvella Therapeutics, Inc. | 2.03B | -1.90% | 30,990 | - |
| 107 | ZBIO | Zenas BioPharma, Inc. | 1.99B | -2.75% | 405,837 | 10.00M |
| 108 | GLUE | Monte Rosa Therapeutics, Inc. | 1.98B | -0.59% | 127,215 | 42.95M |
| 109 | AUPH | Aurinia Pharmaceuticals Inc. | 1.98B | -1.34% | 125,936 | 298.30M |
| 110 | RAPP | Rapport Therapeutics, Inc. | 1.98B | -2.61% | 38,071 | 20.00M |
| 111 | ADMA | ADMA Biologics, Inc. | 1.97B | -1.28% | 336,042 | 509.86M |
| 112 | SNDX | Syndax Pharmaceuticals, Inc. | 1.95B | -2.83% | 170,720 | 217.17M |
| 113 | NBTX | Nanobiotix S.A. | 1.93B | -1.67% | 11,855 | 38.27M |
| 114 | LKFT | Lakefront Biotherapeutics NV | 1.93B | -0.07% | 18,008 | 1.20B |
| 115 | GHRS | GH Research PLC | 1.91B | -1.62% | 28,468 | - |
| 116 | OCUL | Ocular Therapeutix, Inc. | 1.90B | -2.91% | 287,023 | 52.04M |
| 117 | PGEN | Precigen, Inc. | 1.88B | -3.73% | 509,765 | 31.60M |
| 118 | DMRA | Damora Therapeutics, Inc. | 1.86B | -8.18% | 49,860 | - |
| 119 | TYRA | Tyra Biosciences, Inc. | 1.86B | -1.63% | 81,692 | - |
| 120 | BCAX | Bicara Therapeutics Inc. | 1.83B | -1.21% | 39,211 | - |
| 121 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.80B | -1.55% | 378,716 | 204.73M |
| 122 | ABCL | AbCellera Biologics Inc. | 1.80B | -1.09% | 701,630 | 79.21M |
| 123 | GENB | Generate Biomedicines, Inc. | 1.79B | -2.71% | 46,423 | 30.30M |
| 124 | TSHA | Taysha Gene Therapies, Inc. | 1.79B | -1.23% | 249,595 | 7.47M |
| 125 | STOK | Stoke Therapeutics, Inc. | 1.77B | -1.25% | 44,955 | 32.08M |
| 126 | AAPG | Ascentage Pharma Group International | 1.76B | 1.57% | 5,135 | 82.08M |
| 127 | IMCR | Immunocore Holdings plc | 1.75B | -0.49% | 67,647 | 412.81M |
| 128 | SRPT | Sarepta Therapeutics, Inc. | 1.72B | 0.31% | 432,573 | 2.18B |
| 129 | ZYME | Zymeworks Inc. | 1.70B | -1.50% | 69,921 | 81.26M |
| 130 | FTRE | Fortrea Holdings Inc. | 1.67B | -1.51% | 144,323 | 2.71B |
| 131 | MPLT | MapLight Therapeutics, Inc. | 1.63B | -4.21% | 44,202 | - |
| 132 | VIR | Vir Biotechnology, Inc. | 1.60B | 0.85% | 732,495 | 65.50M |
| 133 | RXRX | Recursion Pharmaceuticals, Inc. | 1.59B | -2.92% | 3,292,927 | 66.41M |
| 134 | INVA | Innoviva, Inc. | 1.59B | -0.37% | 64,025 | 420.69M |
| 135 | ANAB | AnaptysBio, Inc. | 1.59B | -0.33% | 128,374 | 232.39M |
| 136 | MAZE | Maze Therapeutics, Inc. | 1.58B | -2.44% | 42,385 | 20.00M |
| 137 | MLTX | MoonLake Immunotherapeutics | 1.58B | -4.94% | 268,505 | - |
| 138 | NTLA | Intellia Therapeutics, Inc. | 1.56B | -2.62% | 537,424 | 66.09M |
| 139 | SEPN | Septerna, Inc. | 1.51B | -0.86% | 24,481 | 72.26M |
| 140 | SVRA | Savara Inc. | 1.45B | -1.88% | 1,446,079 | - |
| 141 | XNCR | Xencor, Inc. | 1.45B | -4.25% | 125,218 | 97.36M |
| 142 | ABSI | Absci Corporation | 1.38B | -1.92% | 432,451 | 1.84M |
| 143 | AKTS | Aktis Oncology, Inc. | 1.35B | -0.69% | 37,616 | 8.28M |
| 144 | AVBP | ArriVent BioPharma, Inc. | 1.35B | 2.40% | 80,438 | - |
| 145 | NVAX | Novavax, Inc. | 1.32B | -0.31% | 484,141 | 596.34M |
| 146 | TRAX | First Tracks Biotherapeutics, Inc. | 1.32B | 1.26% | 122,949 | - |
| 147 | AVLN | Avalyn Pharma Inc. | 1.31B | 1.48% | 80,600 | - |
| 148 | IMTX | Immatics N.V. | 1.27B | -1.01% | 13,319 | 43.00M |
| 149 | INBX | Inhibrx Biosciences, Inc. | 1.26B | -1.99% | 29,715 | 1.30M |
| 150 | ARDX | Ardelyx, Inc. | 1.25B | -0.98% | 378,168 | 427.68M |
| 151 | MNKD | MannKind Corporation | 1.21B | -3.21% | 1,295,801 | 360.78M |
| 152 | FBRX | Forte Biosciences, Inc. | 1.19B | -3.63% | 42,946 | - |
| 153 | JBIO | Jade Biosciences, Inc. | 1.19B | -2.19% | 408,548 | - |
| 154 | CRVS | Corvus Pharmaceuticals, Inc. | 1.18B | -3.04% | 107,594 | - |
| 155 | DRTS | Alpha Tau Medical Ltd. | 1.17B | -2.40% | 138,419 | - |
| 156 | MGTX | MeiraGTx Holdings plc | 1.14B | -1.28% | 37,231 | 79.76M |
| 157 | CAPR | Capricor Therapeutics, Inc. | 1.14B | -0.53% | 279,914 | 11.13M |
| 158 | SPTX | Seaport Therapeutics, Inc. | 1.11B | -0.90% | 14,560 | - |
| 159 | WVE | Wave Life Sciences Ltd. | 1.11B | -0.35% | 408,445 | 71.80M |
| 160 | CGEM | Cullinan Therapeutics, Inc. | 1.11B | -0.17% | 111,687 | - |
| 161 | ORIC | ORIC Pharmaceuticals, Inc. | 1.09B | -2.40% | 189,961 | - |
| 162 | EYPT | EyePoint, Inc. | 1.07B | -2.07% | 118,120 | 7.61M |
| 163 | IVA | Inventiva S.A. | 1.06B | -2.46% | 99,558 | 7.94M |
| 164 | VOR | Vor Biopharma Inc. | 1.03B | -4.74% | 223,909 | - |
| 165 | ANRO | Alto Neuroscience, Inc. | 1.03B | -1.96% | 34,511 | - |
| 166 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.02B | -3.78% | 951,114 | 69.64M |
| 167 | OLMA | Olema Pharmaceuticals, Inc. | 999.26M | -1.29% | 107,803 | - |
| 168 | LBRX | LB Pharmaceuticals Inc | 990.78M | 6.93% | 93,073 | - |
| 169 | AVTX | Avalo Therapeutics, Inc. | 977.38M | -1.83% | 79,968 | 59.00K |
| 170 | JANX | Janux Therapeutics, Inc. | 958.67M | -3.32% | 159,791 | 13.73M |
| 171 | KURA | Kura Oncology, Inc. | 949.89M | -1.74% | 127,547 | 71.64M |
| 172 | SANA | Sana Biotechnology, Inc. | 947.68M | - | 397,009 | - |
| 173 | REPL | Replimune Group, Inc. | 930.95M | 0.82% | 348,713 | - |
| 174 | PHAR | Pharming Group N.V. | 930.25M | 2.10% | 1,134 | 369.49M |
| 175 | GERN | Geron Corporation | 914.17M | -1.04% | 756,525 | 196.12M |
| 176 | PHAT | Phathom Pharmaceuticals, Inc. | 910.27M | 1.87% | 179,979 | 204.89M |
| 177 | TBPH | Theravance Biopharma, Inc. | 874.60M | 0.21% | 44,179 | 109.78M |
| 178 | ODTX | Odyssey Therapeutics, Inc. | 872.82M | 0.05% | 30,585 | 1.06M |
| 179 | ABUS | Arbutus Biopharma Corporation | 871.14M | -2.43% | 158,108 | 191.45M |
| 180 | ANNX | Annexon, Inc. | 847.07M | -4.08% | 366,860 | - |
| 181 | DBVT | DBV Technologies S.A. | 835.25M | -1.83% | 81,580 | 5.04M |
| 182 | SLDB | Solid Biosciences Inc. | 809.26M | -2.84% | 127,599 | - |
| 183 | TENX | Tenax Therapeutics, Inc. | 779.15M | -2.99% | 261,817 | - |
| 184 | ACRS | Aclaris Therapeutics, Inc. | 777.93M | -2.11% | 92,021 | 8.37M |
| 185 | AURA | Aura Biosciences, Inc. | 765.48M | -1.28% | 84,992 | - |
| 186 | DRUG | Bright Minds Biosciences Inc. | 765.45M | -1.99% | 71,551 | - |
| 187 | MNPR | Monopar Therapeutics Inc. | 746.24M | -1.91% | 98,682 | - |
| 188 | DSGN | Design Therapeutics, Inc. | 744.49M | -1.16% | 88,935 | - |
| 189 | CTMX | CytomX Therapeutics, Inc. | 735.84M | -1.17% | 319,752 | 35.54M |
| 190 | CADL | Candel Therapeutics, Inc. | 735.63M | -1.76% | 175,829 | - |
| 191 | CLYM | Climb Bio, Inc. | 729.50M | -2.75% | 79,386 | - |
| 192 | FTH | Faeth Therapeutics, Inc. | 722.06M | -1.27% | 214,605 | - |
| 193 | ZVRA | Zevra Therapeutics, Inc. | 714.70M | -2.89% | 173,715 | 122.29M |
| 194 | NGNE | Neurogene Inc. | 713.98M | -2.32% | 9,173 | 925.00K |
| 195 | OCS | Oculis Holding AG | 707.14M | -2.09% | 52,299 | 1.40M |
| 196 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 701.74M | 0.46% | 63,609 | - |
| 197 | OMER | Omeros Corporation | 701.32M | 1.68% | 297,132 | 9.89M |
| 198 | RIGL | Rigel Pharmaceuticals, Inc. | 696.60M | -4.22% | 60,768 | 299.77M |
| 199 | IMMX | Immix Biopharma, Inc. | 682.00M | 0.10% | 303,509 | - |
| 200 | SGP | SpyGlass Pharma, Inc. | 680.70M | 0.44% | 16,931 | - |
| 201 | ACHV | Achieve Life Sciences, Inc. | 672.42M | 0.77% | 216,330 | - |
| 202 | GYRE | Gyre Therapeutics, Inc. | 666.70M | -1.32% | 7,997 | 117.05M |
| 203 | CBIO | Crescent Biopharma, Inc. | 661.59M | -3.79% | 58,894 | 11.88M |
| 204 | RGNX | REGENXBIO Inc. | 644.18M | 0.97% | 239,938 | 87.82M |
| 205 | ALLO | Allogene Therapeutics, Inc. | 636.81M | -0.27% | 727,153 | 22.00K |
| 206 | SPRY | ARS Pharmaceuticals, Inc. | 627.60M | -0.63% | 841,817 | 98.99M |
| 207 | MDXG | MiMedx Group, Inc. | 624.08M | -3.01% | 124,651 | 389.42M |
| 208 | CRMD | CorMedix Inc. | 622.12M | -3.17% | 115,939 | 400.05M |
| 209 | NVCT | Nuvectis Pharma, Inc. | 610.33M | 1.47% | 35,590 | - |
| 210 | TECX | Tectonic Therapeutic, Inc. | 605.13M | -2.23% | 18,113 | - |
| 211 | FDMT | 4D Molecular Therapeutics, Inc. | 591.77M | -0.48% | 316,564 | 88.24M |
| 212 | SLBT | SL Science Holding Limited | 583.47M | -3.99% | 18,160 | 3.36M |
| 213 | AGMB | AgomAb Therapeutics NV | 573.25M | - | 31,251 | - |
| 214 | PRME | Prime Medicine, Inc. | 563.53M | - | 414,855 | 4.03M |
| 215 | ALT | Altimmune, Inc. | 546.47M | -0.35% | 468,997 | 36.00K |
| 216 | CTNM | Contineum Therapeutics, Inc. | 539.49M | 3.81% | 32,457 | - |
| 217 | ARVN | Arvinas, Inc. | 531.01M | -0.36% | 99,860 | 89.40M |
| 218 | RLMD | Relmada Therapeutics, Inc. | 530.74M | -4.53% | 316,847 | - |
| 219 | RZLT | Rezolute, Inc. | 523.38M | -1.57% | 244,999 | - |
| 220 | EIKN | Eikon Therapeutics, Inc. | 522.09M | -2.69% | 40,066 | - |
| 221 | STTK | Shattuck Labs, Inc. | 518.36M | -6.24% | 146,140 | 1.00M |
| 222 | ZURA | Zura Bio Limited | 514.89M | -4.58% | 91,620 | - |
| 223 | DNA | Ginkgo Bioworks Holdings, Inc. | 511.49M | -0.76% | 88,685 | 151.40M |
| 224 | VSTM | Verastem, Inc. | 510.55M | -3.17% | 208,457 | 49.59M |
| 225 | ASMB | Assembly Biosciences, Inc. | 510.20M | -2.74% | 18,809 | 71.10M |
| 226 | SLN | Silence Therapeutics plc | 506.11M | -1.24% | 77,124 | 839.00K |
| 227 | ANL | Adlai Nortye Ltd. | 494.00M | -5.00% | 63,283 | 5.00M |
| 228 | ARTV | Artiva Biotherapeutics, Inc. | 475.19M | -2.20% | 94,965 | 251.00K |
| 229 | HELP | Cybin Inc. | 474.18M | -5.56% | 574,130 | - |
| 230 | PROK | ProKidney Corp. | 469.70M | -2.51% | 123,493 | 889.00K |
| 231 | VALN | Valneva SE | 461.30M | 0.81% | 1,545 | 180.25M |
| 232 | PRTA | Prothena Corporation plc | 454.95M | -0.69% | 89,266 | 57.94M |
| 233 | CABA | Cabaletta Bio, Inc. | 448.40M | -2.48% | 303,347 | - |
| 234 | KYTX | Kyverna Therapeutics, Inc. | 447.15M | -1.67% | 124,299 | - |
| 235 | OCGN | Ocugen, Inc. | 441.77M | 0.38% | 855,618 | 4.47M |
| 236 | OVID | Ovid Therapeutics Inc. | 436.74M | -2.90% | 352,608 | 7.12M |
| 237 | SGMT | Sagimet Biosciences Inc. | 435.97M | -0.14% | 212,631 | - |
| 238 | EVMN | Evommune, Inc. | 435.82M | -0.98% | 63,034 | 10.00M |
| 239 | PBYI | Puma Biotechnology, Inc. | 426.54M | -2.33% | 55,048 | 227.18M |
| 240 | EDIT | Editas Medicine, Inc. | 423.55M | -4.50% | 243,135 | 38.69M |
| 241 | LRMR | Larimar Therapeutics, Inc. | 422.75M | 3.05% | 285,005 | - |
| 242 | EPRX | Eupraxia Pharmaceuticals Inc. | 416.65M | 4.86% | 538,486 | - |
| 243 | CCCC | C4 Therapeutics, Inc. | 410.76M | -3.00% | 522,342 | 34.86M |
| 244 | VTVT | vTv Therapeutics Inc. | 404.55M | -0.94% | 24,834 | 36.84M |
| 245 | BNTC | Benitec Biopharma Inc. | 402.98M | -1.35% | 8,852 | - |
| 246 | STRO | Sutro Biopharma, Inc. | 402.66M | 5.65% | 120,411 | 99.61M |
| 247 | PRLD | Prelude Therapeutics Incorporated | 394.73M | -1.49% | 24,783 | 16.72M |
| 248 | ENTA | Enanta Pharmaceuticals, Inc. | 389.36M | -0.22% | 20,982 | 69.21M |
| 249 | IPSC | Century Therapeutics, Inc. | 387.76M | -4.02% | 135,110 | 109.16M |
| 250 | AUTL | Autolus Therapeutics plc | 385.91M | -1.02% | 215,489 | 92.62M |
| 251 | AVIR | Atea Pharmaceuticals, Inc. | 382.53M | -1.85% | 28,980 | - |
| 252 | LXEO | Lexeo Therapeutics, Inc. | 379.26M | 3.65% | 172,900 | - |
| 253 | DMAC | DiaMedica Therapeutics Inc. | 377.72M | -0.99% | 19,725 | - |
| 254 | IKT | Inhibikase Therapeutics, Inc. | 372.37M | -2.02% | 138,396 | 1.00 |
| 255 | UPB | Upstream Bio, Inc. | 372.23M | -2.01% | 77,887 | 3.32M |
| 256 | CMPX | Compass Therapeutics, Inc. | 370.98M | -1.90% | 216,305 | 850.00K |
| 257 | RCKT | Rocket Pharmaceuticals, Inc. | 367.44M | -1.03% | 413,175 | - |
| 258 | ABEO | Abeona Therapeutics Inc. | 367.05M | -1.38% | 177,760 | 14.54M |
| 259 | FENC | Fennec Pharmaceuticals Inc. | 352.93M | -2.21% | 24,631 | 51.00M |
| 260 | PALI | Palisade Bio, Inc. | 337.61M | 1.30% | 1,281,037 | - |
| 261 | XFOR | X4 Pharmaceuticals, Inc. | 336.72M | -3.25% | 88,534 | 9.01M |
| 262 | VCRE | Vicore Pharma Holding AB (publ) | 332.85M | - | 177 | 370.61K |
| 263 | ZNTL | Zentalis Pharmaceuticals, Inc. | 330.66M | -7.29% | 314,278 | 26.87M |
| 264 | VNDA | Vanda Pharmaceuticals Inc. | 327.74M | -0.55% | 132,430 | 217.78M |
| 265 | LYEL | Lyell Immunopharma, Inc. | 320.76M | -0.15% | 41,420 | 31.00K |
| 266 | FATE | Fate Therapeutics, Inc. | 312.38M | -5.30% | 365,519 | 6.32M |
| 267 | SLGL | Sol-Gel Technologies Ltd. | 302.38M | 3.08% | 5,878 | 18.47M |
| 268 | TTRX | Turn Therapeutics Inc. | 302.35M | -0.29% | 6,727 | - |
| 269 | FHTX | Foghorn Therapeutics Inc. | 298.27M | -1.55% | 35,634 | 28.22M |
| 270 | ELDN | Eledon Pharmaceuticals, Inc. | 296.84M | -2.78% | 190,057 | - |
| 271 | OABI | OmniAb, Inc. | 295.02M | -2.63% | 123,797 | 28.94M |
| 272 | BCYC | Bicycle Therapeutics plc | 291.11M | 0.24% | 25,762 | 63.50M |
| 273 | IMRX | Immuneering Corporation | 288.55M | - | 163,534 | - |
| 274 | INDP | Indaptus Therapeutics, Inc. | 287.64M | 0.79% | 3,839 | - |
| 275 | NMRA | Neumora Therapeutics, Inc. | 286.26M | -4.33% | 129,872 | - |
| 276 | LCTX | Lineage Cell Therapeutics, Inc. | 275.47M | -3.07% | 196,344 | 14.78M |
| 277 | MGNX | MacroGenics, Inc. | 274.59M | -4.85% | 81,662 | 157.08M |
| 278 | SABS | SAB Biotherapeutics, Inc. | 271.45M | -2.47% | 58,127 | 114.70K |
| 279 | NAGE | Niagen Bioscience, Inc. | 269.76M | -3.15% | 161,854 | 130.42M |
| 280 | ALXO | ALX Oncology Holdings Inc. | 267.11M | -3.17% | 116,368 | - |
| 281 | IFRX | InflaRx N.V. | 263.65M | -1.10% | 110,836 | 33.82K |
| 282 | SRZN | Surrozen, Inc. | 263.32M | -1.35% | 63,071 | 7.49M |
| 283 | QTTB | Q32 Bio Inc. | 263.16M | 0.71% | 208,432 | 53.74M |
| 284 | CNXU | Conexeu Sciences Inc. | 262.23M | 1.55% | 17,875 | - |
| 285 | PRQR | ProQR Therapeutics N.V. | 256.84M | -3.19% | 224,710 | 15.73M |
| 286 | AGEN | Agenus Inc. | 253.30M | 1.43% | 482,753 | 123.87M |
| 287 | OTLK | Outlook Therapeutics, Inc. | 250.58M | -5.63% | 3,808,766 | 333.14K |
| 288 | IRD | Opus Genetics, Inc. | 249.76M | -1.14% | 106,608 | 11.98M |
| 289 | FULC | Fulcrum Therapeutics, Inc. | 241.88M | -1.36% | 291,597 | 80.00M |
| 290 | GALT | Galectin Therapeutics Inc. | 241.69M | -4.55% | 164,593 | - |
| 291 | AVXL | Anavex Life Sciences Corp. | 239.09M | 0.98% | 189,108 | - |
| 292 | RNAC | Cartesian Therapeutics, Inc. | 237.11M | -0.74% | 20,630 | 1.78M |
| 293 | ADAG | Adagene Inc. | 236.87M | -2.58% | 83,807 | 7.67M |
| 294 | CGEN | Compugen Ltd. | 233.15M | -1.00% | 75,796 | 72.66M |
| 295 | TARA | Protara Therapeutics, Inc. | 228.75M | -0.49% | 63,267 | - |
| 296 | TRDA | Entrada Therapeutics, Inc. | 227.01M | -2.48% | 33,248 | 5.74M |
| 297 | CHRS | Coherus Oncology, Inc. | 223.66M | -1.36% | 128,836 | 46.88M |
| 298 | ACIU | AC Immune SA | 219.23M | -3.91% | 38,607 | 4.62M |
| 299 | NAUT | Nautilus Biotechnology, Inc. | 217.30M | 0.59% | 62,993 | - |
| 300 | OBIO | Orchestra BioMed Holdings, Inc. | 215.57M | -2.44% | 44,577 | 32.72M |
| 301 | WHWK | Whitehawk Therapeutics, Inc. | 212.98M | 1.28% | 49,012 | 7.15M |
| 302 | RNA | Atrium Therapeutics, Inc. | 209.20M | -0.49% | 9,937 | 36.68M |
| 303 | GLSI | Greenwich LifeSciences, Inc. | 208.72M | -2.94% | 30,459 | - |
| 304 | NBP | NovaBridge Biosciences | 204.12M | -3.55% | 57,121 | - |
| 305 | NERV | Minerva Neurosciences, Inc. | 202.66M | -2.90% | 16,307 | - |
| 306 | KROS | Keros Therapeutics, Inc. | 201.68M | -3.60% | 30,381 | 33.18M |
| 307 | CLLS | Cellectis S.A. | 201.12M | 8.92% | 9,096 | 75.11M |
| 308 | IMUX | Immunic, Inc. | 196.15M | -4.95% | 96,657 | - |
| 309 | CDXS | Codexis, Inc. | 190.88M | -4.55% | 78,195 | 78.09M |
| 310 | IVVD | Invivyd, Inc. | 190.52M | -5.13% | 830,946 | 55.87M |
| 311 | PLX | Protalix BioTherapeutics, Inc. | 190.15M | - | 77,121 | 76.38M |
| 312 | MENS | Jyong Biotech Ltd. | 190.04M | -0.78% | 51,742 | - |
| 313 | DTIL | Precision BioSciences, Inc. | 189.18M | -3.78% | 39,593 | 45.07M |
| 314 | NRXP | NRx Pharmaceuticals, Inc. | 188.60M | 0.90% | 266,632 | 2.29M |
| 315 | VYGR | Voyager Therapeutics, Inc. | 186.70M | -1.59% | 94,944 | 36.49M |
| 316 | MDWD | MediWound Ltd. | 184.56M | 0.56% | 14,193 | 14.48M |
| 317 | NKTX | Nkarta, Inc. | 183.16M | -0.78% | 113,056 | - |
| 318 | NGEN | NervGen Pharma Corp. | 180.55M | -4.49% | 149,070 | - |
| 319 | ARMP | Armata Pharmaceuticals, Inc. | 179.88M | -5.04% | 11,144 | 5.20M |
| 320 | TNXP | Tonix Pharmaceuticals Holding Corp. | 178.70M | -3.03% | 63,392 | 17.56M |
| 321 | ANTX | AN2 Therapeutics, Inc. | 178.28M | -1.00% | 33,394 | - |
| 322 | HUMA | Humacyte, Inc. | 177.23M | -2.01% | 1,244,997 | 2.02M |
| 323 | TNYA | Tenaya Therapeutics, Inc. | 173.62M | -2.97% | 321,526 | 225.00K |
| 324 | KRRO | Korro Bio, Inc. | 170.62M | -1.09% | 26,118 | 3.84M |
| 325 | ACOG | Alpha Cognition Inc. | 168.97M | -1.65% | 22,265 | 10.83M |
| 326 | OKUR | OnKure Therapeutics, Inc. | 168.05M | -0.24% | 13,974 | - |
| 327 | ARCT | Arcturus Therapeutics Holdings Inc. | 167.98M | -1.34% | 111,612 | 54.71M |
| 328 | ALEC | Alector, Inc. | 167.09M | -2.27% | 52,543 | 18.42M |
| 329 | IPHA | Innate Pharma S.A. | 166.14M | - | 89 | 10.57M |
| 330 | CNTN | Canton Strategic Holdings, Inc. | 165.81M | -0.46% | 69,050 | - |
| 331 | ORMP | Oramed Pharmaceuticals Inc. | 165.34M | 0.50% | 22,894 | 2.00M |
| 332 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 163.79M | -1.56% | 37,401 | - |
| 333 | MIST | Milestone Pharmaceuticals Inc. | 163.26M | -2.44% | 244,113 | 1.78M |
| 334 | CRBU | Caribou Biosciences, Inc. | 162.66M | -0.61% | 154,807 | 11.20M |
| 335 | LENZ | LENZ Therapeutics, Inc. | 162.26M | 0.29% | 135,411 | 20.99M |
| 336 | KPTI | Karyopharm Therapeutics Inc. | 162.04M | -9.09% | 218,488 | 151.12M |
| 337 | CAMP | Camp4 Therapeutics Corporation | 161.49M | -2.51% | 13,786 | 3.93M |
| 338 | EQ | Equillium, Inc. | 159.96M | -3.80% | 69,400 | 4.39M |
| 339 | ABOS | Acumen Pharmaceuticals, Inc. | 158.18M | -1.79% | 51,142 | - |
| 340 | KZIA | Kazia Therapeutics Limited | 158.15M | -2.19% | 11,746 | 1.27M |
| 341 | YDES | YD Bio Limited | 156.81M | -1.76% | 29,190 | 510.36K |
| 342 | UNCY | Unicycive Therapeutics, Inc. | 153.40M | -1.58% | 243,913 | - |
| 343 | MOLN | Molecular Partners AG | 147.80M | -3.41% | 232 | 856.30K |
| 344 | CUE | Cue Biopharma, Inc. | 141.76M | 0.87% | 19,479 | 32.73M |
| 345 | HURA | TuHURA Biosciences, Inc. | 141.69M | 0.68% | 35,896 | - |
| 346 | CBUS | Cibus, Inc. | 138.92M | -2.15% | 14,264 | 4.29M |
| 347 | CNTB | Connect Biopharma Holdings Limited | 137.89M | -0.90% | 23,626 | 233.00K |
| 348 | PEPG | PepGen Inc. | 135.57M | -7.55% | 340,340 | - |
| 349 | PYXS | Pyxis Oncology, Inc. | 134.95M | -4.48% | 100,238 | 13.86M |
| 350 | TLSA | Tiziana Life Sciences Ltd | 132.54M | 2.50% | 100,022 | - |
| 351 | GNLX | Genelux Corporation | 132.34M | 3.11% | 33,781 | 8.00K |
| 352 | AARD | Aardvark Therapeutics, Inc. | 130.13M | -1.89% | 21,910 | - |
| 353 | PMN | ProMIS Neurosciences, Inc. | 128.24M | -1.31% | 13,467 | - |
| 354 | ENGN | enGene Therapeutics Inc. | 126.61M | -2.07% | 112,742 | - |
| 355 | VANI | Vivani Medical, Inc. | 125.47M | 1.75% | 94,357 | - |
| 356 | GUTS | Fractyl Health, Inc. | 125.06M | 2.24% | 358,393 | 3.00K |
| 357 | ANIX | Anixa Biosciences, Inc. | 124.18M | 2.53% | 231,982 | - |
| 358 | SPRB | Spruce Biosciences, Inc. | 122.19M | -2.81% | 9,026 | 697.00K |
| 359 | FBIO | Fortress Biotech, Inc. | 118.92M | 1.42% | 198,101 | 66.16M |
| 360 | SEER | Seer, Inc. | 113.54M | -1.67% | 30,002 | 15.17M |
| 361 | PLYX | Polaryx Therapeutics, Inc. | 110.07M | 0.22% | 10,367 | - |
| 362 | BDTX | Black Diamond Therapeutics, Inc. | 105.15M | -1.87% | 42,577 | 70.00M |
| 363 | COYA | Coya Therapeutics, Inc. | 104.62M | -1.98% | 17,199 | 7.94M |
| 364 | ALDX | Aldeyra Therapeutics, Inc. | 104.36M | -1.14% | 124,290 | - |
| 365 | ONCY | Oncolytics Biotech Inc. | 103.29M | 0.80% | 437,257 | - |
| 366 | ICCC | ImmuCell Corporation | 99.88M | -1.38% | 8,248 | 29.93M |
| 367 | ENTX | Entera Bio Ltd. | 97.59M | 1.02% | 16,365 | 42.00K |
| 368 | NTHI | NeOnc Technologies Holdings, Inc. | 95.95M | 9.79% | 15,228 | 39.99K |
| 369 | PTHS | Pelthos Therapeutics Inc. | 95.23M | 2.01% | 4,393 | 27.70M |
| 370 | VRCA | Verrica Pharmaceuticals Inc. | 94.48M | 1.10% | 8,753 | 37.16M |
| 371 | KLRS | Kalaris Therapeutics, Inc. | 93.27M | -2.97% | 25,521 | - |
| 372 | BMEA | Biomea Fusion, Inc. | 92.54M | -3.76% | 92,813 | - |
| 373 | HRTX | Heron Therapeutics, Inc. | 90.44M | 0.13% | 434,979 | 150.71M |
| 374 | INO | Inovio Pharmaceuticals, Inc. | 88.86M | -1.82% | 388,976 | 65.34K |
| 375 | CGTX | Cognition Therapeutics, Inc. | 88.41M | -1.22% | 47,971 | - |
| 376 | RLYB | Rallybio Corporation | 88.40M | -1.33% | 4,765 | 858.00K |
| 377 | NRXS | NeurAxis, Inc. | 87.31M | 0.57% | 3,132 | 4.28M |
| 378 | RANI | Rani Therapeutics Holdings, Inc. | 86.84M | 1.45% | 545,096 | 3.17M |
| 379 | CSBR | Champions Oncology, Inc. | 85.13M | 0.49% | 226 | 57.95M |
| 380 | ACET | Adicet Bio, Inc. | 84.01M | -1.48% | 5,298 | - |
| 381 | ATHE | Alterity Therapeutics Limited | 83.86M | -5.12% | 821 | 4.43M |
| 382 | ALPS | Alps Group Inc | 81.79M | 2.82% | 2,387 | 3.74M |
| 383 | RNTX | Rein Therapeutics Inc. | 80.03M | -3.87% | 52,131 | - |
| 384 | MAIA | MAIA Biotechnology, Inc. | 78.43M | -3.01% | 89,070 | - |
| 385 | TELO | Telomir Pharmaceuticals, Inc. | 77.72M | 4.63% | 64,117 | - |
| 386 | OKYO | OKYO Pharma Limited | 77.14M | 2.08% | 56,478 | - |
| 387 | SPRO | Spero Therapeutics, Inc. | 76.72M | -3.99% | 377,749 | 61.19M |
| 388 | GANX | Gain Therapeutics, Inc. | 76.56M | -2.45% | 54,404 | - |
| 389 | PYPD | PolyPid Ltd. | 75.74M | 5.61% | 200,572 | - |
| 390 | ENLV | Enlivex Ltd. | 75.69M | -0.42% | 14,133 | - |
| 391 | LONA | LeonaBio, Inc. | 74.96M | - | 880 | - |
| 392 | ATRA | Atara Biotherapeutics, Inc. | 74.61M | -4.05% | 7,277 | 23.14M |
| 393 | ACRV | Acrivon Therapeutics, Inc. | 74.26M | -0.86% | 19,277 | - |
| 394 | ANVS | Annovis Bio, Inc. | 73.60M | -1.14% | 94,337 | - |
| 395 | HYFT | MindWalk Holdings Corp. | 72.02M | -0.68% | 84,306 | 20.70M |
| 396 | GOSS | Gossamer Bio, Inc. | 70.93M | -6.27% | 2,707,190 | 55.54M |
| 397 | OSTX | OS Therapies Incorporated | 70.82M | 1.92% | 69,075 | - |
| 398 | PMVP | PMV Pharmaceuticals, Inc. | 68.80M | -1.53% | 5,107 | - |
| 399 | IBIO | iBio, Inc. | 68.06M | -2.84% | 102,726 | 300.00K |
| 400 | IMA | ImageneBio, Inc. | 67.67M | - | 135 | 800.00K |
| 401 | XBIT | XBiotech Inc. | 67.07M | -1.79% | 33,140 | - |
| 402 | PLRX | Pliant Therapeutics, Inc. | 66.25M | -1.83% | 456,331 | - |
| 403 | MNOV | MediciNova, Inc. | 65.46M | - | 10,663 | 596.64K |
| 404 | CING | Cingulate Inc. | 64.25M | -0.10% | 35,180 | - |
| 405 | TCRX | TScan Therapeutics, Inc. | 62.16M | 1.15% | 31,478 | 9.14M |
| 406 | CNTX | Context Therapeutics Inc. | 58.25M | 0.63% | 519,365 | - |
| 407 | BOLD | Boundless Bio, Inc. | 57.95M | 4.03% | 80,374 | - |
| 408 | ELTX | Elicio Therapeutics, Inc. | 57.60M | -1.95% | 90,322 | - |
| 409 | CRDF | Cardiff Oncology, Inc. | 57.55M | 0.20% | 203,118 | 525.00K |
| 410 | INKT | MiNK Therapeutics, Inc. | 55.05M | -0.18% | 2,232 | - |
| 411 | VRXA | Veraxa Biotech AG | 54.22M | 2.38% | 45,859 | - |
| 412 | XLO | Xilio Therapeutics, Inc. | 52.11M | 0.11% | 7,613 | 53.48M |
| 413 | IMMP | Immutep Limited | 51.65M | 0.20% | 31,627 | 5.28M |
| 414 | BYSI | BeyondSpring Inc. | 51.40M | - | 2,807 | 1.88M |
| 415 | DYAI | Dyadic International, Inc. | 51.29M | -4.24% | 209,341 | 3.81M |
| 416 | INMB | INmune Bio Inc. | 50.78M | -3.05% | 76,456 | 50.00K |
| 417 | EDSA | Edesa Biotech, Inc. | 50.68M | -5.47% | 20,467 | - |
| 418 | MCRB | Seres Therapeutics, Inc. | 50.45M | -0.76% | 5,932 | 1.15M |
| 419 | TIL | Instil Bio, Inc. | 49.51M | 0.69% | 2,504 | - |
| 420 | MREO | Mereo BioPharma Group plc | 49.47M | 1.34% | 159,401 | 500.00K |
| 421 | ELOX | Eloxx Pharmaceuticals, Inc. | 49.24M | 1.67% | 52,701 | - |
| 422 | IBO | Impact BioMedical Inc. | 49.05M | 3.15% | 725 | 39.00K |
| 423 | ATYR | aTyr Pharma, Inc. | 48.81M | 2.45% | 177,779 | 190.00K |
| 424 | FLNA | Filana Therapeutics, Inc. | 47.34M | -2.97% | 174,369 | - |
| 425 | RADX | Radiopharm Theranostics Limited | 47.20M | - | - | 10.86M |
| 426 | MGX | Metagenomi Therapeutics, Inc. | 46.68M | 1.64% | 158,523 | 22.33M |
| 427 | DWTX | Dogwood Therapeutics, Inc. | 45.40M | -3.57% | 20,372 | - |
| 428 | EXOZ | eXoZymes, Inc. | 44.26M | -1.97% | 800 | -700.00 |
| 429 | HYPD | Hyperion DeFi, Inc. | 41.91M | 0.18% | 44,212 | 1.04M |
| 430 | PDSB | PDS Biotechnology Corporation | 40.97M | -3.42% | 27,997 | - |
| 431 | APLM | Apollomics, Inc. | 40.85M | -0.56% | 4,092 | 8.84M |
| 432 | GNTA | Genenta Science S.p.A. | 39.40M | 1.21% | 34,713 | - |
| 433 | CRVO | CervoMed Inc. | 39.36M | 0.69% | 82,422 | 2.09M |
| 434 | RNXT | RenovoRx, Inc. | 39.24M | -0.87% | 45,448 | 1.49M |
| 435 | GRCE | Grace Therapeutics, Inc. | 38.89M | -1.65% | 42,971 | - |
| 436 | NTRB | Nutriband Inc. | 37.44M | - | 6,144 | 1.80M |
| 437 | VERU | Veru Inc. | 36.76M | -2.14% | 37,650 | 16.89M |
| 438 | LTRN | Lantern Pharma Inc. | 36.36M | -3.06% | 10,077 | - |
| 439 | LITS | Lite Strategy, Inc. | 35.04M | 2.99% | 68,161 | - |
| 440 | NNVC | NanoViricides, Inc. | 34.74M | -4.69% | 287,909 | - |
| 441 | ESLA | Estrella Immunopharma, Inc. | 34.42M | -0.01% | 529 | - |
| 442 | ALGS | Aligos Therapeutics, Inc. | 33.11M | -1.65% | 4,808 | 4.71M |
| 443 | BCTX | BriaCell Therapeutics Corp. | 32.34M | -3.73% | 18,977 | - |
| 444 | SER | Serina Therapeutics, Inc. | 32.09M | 2.39% | 5,388 | 130.00K |
| 445 | ACTU | Actuate Therapeutics, Inc. | 32.06M | -0.74% | 13,966 | - |
| 446 | ABVC | ABVC BioPharma, Inc. | 30.29M | -2.54% | 24,824 | 797.92K |
| 447 | KYNB | Kyntra Bio, Inc. | 29.11M | -1.51% | 3,256 | 7.44M |
| 448 | VYNE | VYNE Therapeutics Inc. | 28.37M | -4.70% | 436,279 | 454.00K |
| 449 | ATNM | Actinium Pharmaceuticals, Inc. | 27.77M | -1.64% | 13,795 | 90.00K |
| 450 | IGC | IGC Pharma, Inc. | 26.97M | 0.90% | 60,046 | 1.11M |
| 451 | BRNS | Barinthus Biotherapeutics plc | 26.56M | 7.26% | 1,839 | 14.97M |
| 452 | PSTV | Plus Therapeutics, Inc. | 26.04M | -3.50% | 15,777 | 5.18M |
| 453 | TVRD | Tvardi Therapeutics, Inc. | 25.70M | -4.20% | 217,118 | - |
| 454 | EVAX | Evaxion A/S | 25.35M | 0.66% | 2,490 | 7.53M |
| 455 | PLRZ | Polyrizon Ltd. | 25.27M | 0.07% | 1,713 | - |
| 456 | GRDX | GridAI Technologies Corp. | 23.72M | 0.71% | 4,747 | - |
| 457 | CELU | Celularity Inc. | 23.45M | - | 3,858 | 26.55M |
| 458 | SKYE | Skye Bioscience, Inc. | 23.29M | 3.54% | 19,230 | - |
| 459 | NRSN | NeuroSense Therapeutics Ltd. | 23.24M | -6.07% | 54,272 | - |
| 460 | JSPR | Jasper Therapeutics, Inc. | 21.04M | -2.42% | 527,918 | - |
| 461 | MRKR | Marker Therapeutics, Inc. | 21.01M | -0.79% | 25,371 | 3.55M |
| 462 | ATOS | Atossa Therapeutics, Inc. | 20.93M | 1.25% | 8,763 | - |
| 463 | CVM | CEL-SCI Corporation | 20.71M | -5.20% | 98,499 | - |
| 464 | CLRB | Cellectar Biosciences, Inc. | 20.19M | -2.09% | 19,965 | - |
| 465 | PLUR | Pluri Inc. | 20.18M | -4.10% | 16,556 | 1.08M |
| 466 | LSTA | Lisata Therapeutics, Inc. | 19.85M | -2.68% | 31,908 | 170.00K |
| 467 | LGVN | Longeveron Inc. | 19.71M | 2.01% | 21,775 | 1.22M |
| 468 | NCEL | NewcelX Ltd. | 19.65M | -4.20% | 1,650 | - |
| 469 | ALLR | Allarity Therapeutics, Inc. | 19.41M | - | 7,144 | 345.00K |
| 470 | QNTM | Quantum BioPharma Ltd. | 19.11M | -5.30% | 21,387 | - |
| 471 | HOWL | Werewolf Therapeutics, Inc. | 18.49M | 4.82% | 34,871 | 1.14M |
| 472 | DARE | Daré Bioscience, Inc. | 18.42M | -1.60% | 115,392 | 1.16M |
| 473 | NEUP | Neuphoria Therapeutics Inc. | 18.27M | 1.20% | 1,690 | -13.27K |
| 474 | LPCN | Lipocine Inc. | 18.22M | 0.91% | 975 | 2.00M |
| 475 | NXTC | NextCure, Inc. | 17.99M | -2.54% | 85,691 | - |
| 476 | TVGN | Tevogen Bio Holdings Inc. | 17.96M | 4.86% | 812 | - |
| 477 | AKTX | Akari Therapeutics, Plc | 17.49M | 7.48% | 20,560 | - |
| 478 | QNCX | Quince Therapeutics, Inc. | 17.21M | -6.28% | 17,623 | - |
| 479 | MLEC | Moolec Science SA | 16.64M | -5.33% | 10,170 | 7.83M |
| 480 | PTN | Palatin Technologies, Inc. | 16.39M | -1.28% | 623 | 12.88M |
| 481 | CTXR | Citius Pharmaceuticals, Inc. | 16.29M | 8.80% | 197,484 | 5.61M |
| 482 | ICU | SeaStar Medical Holding Corporation | 15.76M | 1.55% | 7,110 | 1.44M |
| 483 | PASG | Passage Bio, Inc. | 15.62M | -0.81% | 21,534 | - |
| 484 | HIND | Vyome Holdings, Inc. | 15.44M | 0.92% | 5,102 | 152.72K |
| 485 | OSRH | OSR Health, Inc. | 15.44M | 0.53% | 280,256 | 2.63M |
| 486 | KTTA | Pasithea Therapeutics Corp. | 15.37M | 1.14% | 106,348 | - |
| 487 | CYCN | Cyclerion Therapeutics, Inc. | 15.35M | -2.03% | 6,014 | 1.99M |
| 488 | TPST | Tempest Therapeutics, Inc. | 14.54M | -0.84% | 37,557 | - |
| 489 | LEXX | Lexaria Bioscience Corp. | 14.38M | 4.73% | 10,196 | 194.00K |
| 490 | SNTI | Senti Biosciences Holdings, Inc. | 14.02M | -2.26% | 59,771 | 38.00K |
| 491 | KALA | KALA BIO, Inc. | 13.48M | -1.15% | 26,087 | - |
| 492 | BLRX | BioLineRx Ltd. | 12.91M | -0.68% | 1,960 | 1.40M |
| 493 | PHIO | Phio Pharmaceuticals Corp. | 12.90M | -1.77% | 86,067 | - |
| 494 | COCP | Cocrystal Pharma, Inc. | 12.87M | 0.33% | 2,574 | 225.00K |
| 495 | GTBP | GT Biopharma, Inc. | 12.62M | -2.32% | 92,365 | - |
| 496 | LNAI | Lunai Bioworks Inc. | 12.24M | -2.17% | 6,155 | 20.94K |
| 497 | CALC | CalciMedica, Inc. | 12.18M | 8.56% | 156,442 | - |
| 498 | INAB | IN8bio, Inc. | 12.11M | -0.81% | 2,060 | - |
| 499 | INTS | Intensity Therapeutics, Inc. | 11.96M | 0.57% | 617 | - |
| 500 | XCUR | Exicure, Inc. | 11.77M | -4.28% | 11,851 | 500.00K |